Skip to content

Author

E. Wiesen

We have 2 of 51 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.

BACKGROUND In 2023, novel oral polio vaccine type 2 (nOPV2) was used to respond to an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Kenya. We assessed the immunogenicity of one and two doses of nOPV2 administered during outbreak response. METHODS An observational cohort study was conducted fro...

A. Anand, Damaris Jepkosgei, C. Mwachari et al. · 0 citations
Review Open access Aug 2026

Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020-2023.

The cVDPV1 outbreak in Madagascar demonstrated the potential for significant adult involvement and high mortality in polio outbreaks, and highlighted the importance of inclusive vaccination strategies and tailored approaches in similar settings.

Kpandja Djawe, Eric Aigbogun, Joseph Souba Zoumanigui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.